O’Leary, Meghan C. http://orcid.org/0000-0001-6954-7141
Reuland, Daniel S. http://orcid.org/0000-0002-7839-6581
Correa, Sara Y. http://orcid.org/0000-0002-3129-895X
Moore, Alexis A. http://orcid.org/0000-0002-1740-6627
Malo, Teri L. http://orcid.org/0000-0002-5620-4841
Tan, Xianming http://orcid.org/0000-0002-5478-2269
Rohweder, Catherine L. http://orcid.org/0000-0002-7684-9671
Wheeler, Stephanie B. http://orcid.org/0000-0002-3399-9047
Brenner, Alison T. http://orcid.org/0000-0001-6421-9982
Clinical trials referenced in this document:
Documents that mention this clinical trial
Uptake of colorectal cancer screening after mailed fecal immunochemical test (FIT) outreach in a newly eligible 45–49-year-old community health center population
https://doi.org/10.1007/s10552-023-01717-8
Funding for this research was provided by:
National Cancer Institute of the National Institutes of Health (UH3 CA233251, UH3 CA233251, UH3 CA233251, UH3 CA233251, UH3 CA233251, UH3 CA233251, UH3 CA233251, UH3 CA233251, UH3 CA233251)
National Center for Chronic Disease Prevention and Health Promotion of the Centers for Disease Control and Prevention, U.S. Department of Health and Human Services (U48 DP006400, U48 DP006400, U48 DP006400)
Article History
Received: 4 November 2022
Accepted: 15 May 2023
First Online: 10 June 2023
Declarations
:
: SBW receives funding paid to her institution from Pfizer Foundation and AstraZeneca for unrelated work. The other authors declare that they have no competing interests.
: This study was approved by the Institutional Review Board at the University of North Carolina at Chapel Hill (#20–0827).
: The IRB granted a waiver of signed consent.
: Not applicable.